Search Within

Vincent Miller

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (31)
Groups
  1. GSK Faculty (64)
  2. Human Oncology and Pathogenesis Program (64)
  3. Tow Center for Developmental Oncology (TCDO) (62)
  4. Department of Pathology and Laboratory Medicine (61)
  5. Department of Medicine (59)
  6. Solid Tumor Oncology Division (55)

More Groups

People
  1. Marc Ladanyi (59)
  2. Mark Kris (46)
  3. Gregory Riely (44)
  4. William Pao (33)
  5. Maureen Zakowski (29)
  6. Maria Arcila (21)

More People

Years
  1. 2019 (1)
  2. 2016 (1)
  3. 2015 (2)
  4. 2014 (3)
  5. 2013 (1)
  6. 2012 (7)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Clinical Cancer Research (12)
  3. Journal of Molecular Diagnostics (5)
  4. Journal of Thoracic Oncology (4)
  5. Laboratory Investigation (3)
  6. Modern Pathology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (16)
  3. Elsevier Science, Inc. (5)
  4. Nature Publishing Group (5)
  5. Elsevier Inc. (4)
  6. Nature Research (3)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma
    Journal Article

    Riely, G. J.; Kris, M. G.; Rosenbaum, D.; Marks, J.; Li, A.; Chitale, D. A.; Nafa, K.; Riedel, E. R.; Hsu, M.; Pao, W.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib
    Journal Article

    Miller, V. A.; Riely, G. J.; Zakowski, M. F.; Li, A. R.; Patel, J. D.; Heelan, R. T.; Kris, M. G.; Sandler, A. B.; Carbone, D. P.; Tsao, A.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression
    Journal Article

    Li, A. R.; Chitale, D.; Riely, G. J.; Pao, W.; Miller, V. A.; Zakowski, M. F.; Rusch, V.; Kris, M. G.; Ladanyi, M.
    Journal of Molecular Diagnostics (2008)

    Fulltext@MSK | Save
  • Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma
    Journal Article

    Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Smoking history and frequency of somatic KRAS mutations in adenocarcinoma of the lung
    Meeting Abstract

    Miller, V. A.; Riely, G. J.; Kris, M. G.; Rosenbaum, D.; Marks, J.; Li, A.; Chitale, D.; Nafa, K.; Pao, W.; Ladanyi, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • EGFR mutations in lung adenocarcinomas: Clinical testing experience in 334 consecutive cases and relationship to EGFR gene copy number and immunohistochemical expression
    Meeting Abstract

    Li, A. R.; Chitale, D.; Riely, G. J.; Pao, W.; Ma, Y.; Zheng, T.; Miller, V. A.; Zakowski, M. F.; Rusch, V.; Kris, M. G.; more...
    Journal of Molecular Diagnostics (2007)

    Fulltext@MSK | Save
  • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
    Journal Article

    Fury, M. G.; Solit, D. B.; Su, Y. B.; Rosen, N.; Sirotnak, F. M.; Smith, R. P.; Azzoli, C. G.; Gomez, J. E.; Miller, V. A.; Kris, M. G.; more...
    Cancer Chemotherapy and Pharmacology (2007)

    Fulltext@MSK | Save
  • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    Journal Article

    Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2007)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
    Meeting Abstract

    Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Cancer Research (2006)

    Fulltext@MSK | Save